BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5384300)

  • 1. [Propranolol treatment in thyrotoxicosis].
    Cullhed I; Parrow A
    Lakartidningen; 1969 Sep; 66(39):3961-5. PubMed ID: 5384300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blocking of adrenergic beta receptors with propranolol in the treatment of thyrotoxicosis].
    Felt V
    Cas Lek Cesk; 1969 Sep; 108(38):1124-7. PubMed ID: 5810135
    [No Abstract]   [Full Text] [Related]  

  • 3. [On preoperative and postoperative treatment of severe hyperthyroidism using propranolol].
    Höfer R; Keminger K; Kraupp O; Seidl H; Steinbereithner K
    Wien Med Wochenschr; 1969 Feb; 119(5):89-94. PubMed ID: 4182147
    [No Abstract]   [Full Text] [Related]  

  • 4. Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis.
    Felt V
    Rev Czech Med; 1970; 16(3):140-4. PubMed ID: 4393594
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics in drug therapy. I: Propranolol hydrochloride as adjunct therapy in the treatment of thyrotoxicosis.
    Robayo JR
    Am J Hosp Pharm; 1976 Feb; 33(2):169-73. PubMed ID: 56890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol dosage in thyrotoxicosis.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):658-61. PubMed ID: 7410541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propranolol treatment of thyrotoxicosis].
    Karlberg B
    Lakartidningen; 1970 Dec; 67(50):5917-22. PubMed ID: 4395268
    [No Abstract]   [Full Text] [Related]  

  • 8. Propranolol and radioactive iodine in the treatment of thyrotoxicosis.
    Hadden DR; Lowe DC; Montgomery DA; Shanks RG; Weaver JA
    Br J Pharmacol; 1970 May; 39(1):198P. PubMed ID: 4192641
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of propranolol in thyrotoxicosis.
    Shanks RG; Hadden DR; Lowe DC; McDevitt DG; Montgomery DA
    Lancet; 1969 May; 1(7603):993-4. PubMed ID: 4181181
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol dynamics in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1980 Jul; 28(1):40-4. PubMed ID: 7389252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic blockade. A new approach to hyperthyroidism during pregnancy.
    Langer A; Hung CT; Mc A'nulty JA; Harrigan JT; Washington E
    Obstet Gynecol; 1974 Aug; 44(2):181-6. PubMed ID: 4422339
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis.
    Chapdelaine A; Coulombe R; LeLorier J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):308-12. PubMed ID: 794003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the effect of the sympathic beta-receptor blocking agent propranolol on heart rate in hyperthyroidism].
    Tragl KH; Klotz HG; Geyer G
    Wien Klin Wochenschr; 1967 May; 79(18):352-4. PubMed ID: 5585993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adrenergic beta blockaders in hyperthyroidism (adrenergic beta block with propranolol as the sole preparatory treatment of hyperthyroidism in parital thyroidectomy].
    Ramírez Del Villar E; Wurst Zevallos G; Bouroncle Carreón M; Uribe LJ
    Rev Neuropsiquiatr; 1973 Jun; 36(2):107-16. PubMed ID: 4793306
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol: an adjunct to definitive treatment of thyrotoxicosis.
    Friedenberg RC
    Rocky Mt Med J; 1971 Sep; 68(9):41-3. PubMed ID: 5096714
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of thyrotoxicosis with beta-blocking agents].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of inderal on the heart of thyrotoxicosis patients (a clinico-roentgenologic study)].
    Astapov BM; Bogoliubov VM; Matveenko EG; Konstantinov IuN; Sorokina VG
    Klin Med (Mosk); 1972 Aug; 50(8):90-5. PubMed ID: 4660362
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of severe thyrotoxicosis with potassium iodide and propranolol.
    Nicol EF; Irvine WJ
    Scott Med J; 1982 Apr; 27(2):172-4. PubMed ID: 7089529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of adrenergic beta blockaders in thyrotoxicosis and hypothyroidism].
    Feldstein CA; Duhart JE; Henry EC; Degrossi OJ
    Prensa Med Argent; 1970 May; 57(9):454-8. PubMed ID: 4397115
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenergic blockade in thyrotoxicosis.
    Pimstone BL
    S Afr Med J; 1969 Dec; ():Suppl:27-30. PubMed ID: 5372955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.